Overview
Rheos is a precision medicine company using insights from immunometabolism to bring novel therapeutics to patients suffering from autoimmune diseases. Our proprietary platform elucidates the complexities and heterogeneity of immune-mediated disease by investigating multi-omic datasets through a metabolic lens. This insight drives a deep pipeline of biomarker-enabled small molecule precision therapies.